Concepedia

Publication | Open Access

Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes

DOIFull Paper Access

30

Citations

35

References

2020

Year

Erik J.M. van Bommel, Mark M. Smits, Danique Ruiter, Marcel H.A. Muskiet, Mark H.H. Kramer, Max Nieuwdorp, Daan J. Touw, Hiddo J.L. Heerspink, Jaap A. Joles, Daniël H. van Raalte
Journal of Hypertension

Abstract

Dapagliflozin seemingly influences systemic and renal hemodynamics independently and beyond glucose lowering in people with type 2 diabetes.This clinical trial was registered at https://clinicalTrials.gov (ID: NCT02682563).

References

YearCitations

Page 1